CSL Limited
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
| Company type | Public |
|---|---|
| |
| Industry | Biotechnology |
| Founded | 1916 (Federal government department), 1994 (privatised) |
| Headquarters | Parkville, Melbourne, Victoria, Australia (Global), |
Key people | Paul McKenzie (CEO) |
| Products | blood plasma, vaccines, antivenom, other laboratory and medical products |
| Revenue | US$10.61 billion (2021)) |
| US$1.919 billion (2021) | |
Number of employees | 30,000 person (2021) |
| Divisions |
|
| Website | www |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.